Aileron Therapeutics Inc (ALRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 4,192 | 5,028 | 4,400 | 6,876 | 7,349 |
| Operating Income | -4,192 | -5,028 | -4,400 | -6,876 | -7,349 |
| Other Income | -804 | 5 | 10 | 128 | 114 |
| Pre-tax Income | -4,996 | -5,023 | -4,390 | -6,748 | -7,235 |
| Net Income Continuous | -4,996 | -5,023 | -4,390 | -6,748 | -7,235 |
| Net Income | $-4,996 | $-5,023 | $-4,390 | $-6,748 | $-7,235 |
| EPS Basic Total Ops | -2.00 | -2.60 | -2.80 | -4.80 | -3.40 |
| EPS Basic Continuous Ops | -1.92 | -2.55 | -2.81 | -4.85 | -3.42 |
| EPS Diluted Total Ops | -2.00 | -2.60 | -2.80 | -4.80 | -3.40 |
| EPS Diluted Continuous Ops | -1.92 | -2.55 | -2.81 | -4.85 | -3.42 |
| EBITDA(a) | $-4,172 | $-4,997 | $-4,337 | $-6,836 | $-7,335 |